Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes
Authors
Keywords
-
Journal
CANCER
Volume 121, Issue 17, Pages 2883-2891
Publisher
Wiley
Online
2015-05-01
DOI
10.1002/cncr.29438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group
- (2014) Lev Shvidel et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
- (2013) Sameer A. Parikh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
- (2013) Susan O'Brien et al. LANCET ONCOLOGY
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia
- (2013) Tobias Svensson et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
- (2012) Jane A. Freeman et al. LEUKEMIA & LYMPHOMA
- Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia
- (2012) Dimitrios P. Kontoyiannis et al. LEUKEMIA & LYMPHOMA
- Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia
- (2011) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
- (2010) Tait D. Shanafelt et al. CANCER
- Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia
- (2010) L. VARGA et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Infections and serum IgG levels in patients with chronic lymphocytic leukemia
- (2010) M. Itala et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study
- (2009) H.-T. Tsai et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation